I Raz Selected Research

I Raz Research Topics

Disease

9	Type 2 Diabetes Mellitus (MODY) 05/2015 - 09/2001
4	Diabetes Mellitus 02/2016 - 07/2013
4	Body Weight (Weight, Body) 05/2014 - 11/2004
2	Weight Gain 01/2016 - 11/2004
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2007 - 11/2001
1	Overweight 02/2016
1	Obesity 02/2016
1	Neoplasms (Cancer) 02/2016
1	Myocardial Infarction 02/2016
1	Heart Failure 10/2015
1	Hypoglycemia (Reactive Hypoglycemia) 05/2014
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2013
1	Albuminuria 07/2013
1	Inflammation (Inflammations) 07/2013
1	Insulin Resistance 07/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2013
1	Hyperinsulinism (Hyperinsulinemia) 10/2012
1	Gestational Diabetes (Gestational Diabetes Mellitus) 04/2009
1	Periodontitis 01/2008
1	Kidney Diseases (Kidney Disease) 09/2006
1	Hypertension (High Blood Pressure) 09/2006
1	Proteinuria 09/2006
1	Ulcer 11/2004
1	Wounds and Injuries (Trauma) 11/2004
1	Diabetic Foot 11/2004
1	Atrophy 12/2001
1	Hypertrophy 12/2001
1	Renovascular Hypertension (Goldblatt Syndrome) 12/2001
1	Ischemia 12/2001
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2001
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2000
1	Experimental Diabetes Mellitus 08/2000
1	Retinal Neovascularization 01/2000
1	Hypoxia (Hypoxemia) 01/2000

Drug/Important Bio-Agent (IBA)

8	Insulin (Novolin)FDA Link 02/2016 - 11/2001
4	saxagliptin FDA Link 02/2016 - 07/2013
4	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 11/2004
3	Peptides (Polypeptides)IBA 05/2007 - 11/2001
2	Hypoglycemic Agents (Hypoglycemics)IBA 05/2015 - 07/2004
2	Irbesartan FDA LinkGeneric 09/2006 - 09/2001
2	Angiotensin Receptor AntagonistsIBA 09/2006 - 09/2001
1	Liraglutide FDA Link 02/2016
1	Antihypertensive Agents (Antihypertensives)IBA 02/2016
1	HDL CholesterolIBA 02/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2016
1	Triglycerides (Triacylglycerol)IBA 02/2016
1	LipidsIBA 02/2016
1	dulaglutideIBA 01/2016
1	Losartan (Cozaar)FDA LinkGeneric 02/2014
1	Angiotensin IIIBA 02/2014
1	Biomarkers (Surrogate Marker)IBA 07/2013
1	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2013
1	insulin aspart protamine drug combination 30:70 insulin aspartIBA 11/2009
1	Immunoglobulin A (IgA)IBA 01/2008
1	Immunoglobulins (Immunoglobulin)IBA 01/2008
1	AntibodiesIBA 01/2008
1	Sitagliptin Phosphate (Januvia)FDA Link 11/2006
1	Ramipril (Altace)FDA LinkGeneric 09/2006
1	AlbuminsIBA 09/2006
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2006
1	Insulin Aspart (NovoLog)FDA Link 11/2004
1	Insulin Detemir (Levemir)FDA Link 11/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2004
1	Ribonucleases (Ribonuclease)IBA 12/2001
1	Messenger RNA (mRNA)IBA 12/2001
1	SolutionsIBA 12/2001
1	Proteins (Proteins, Gene)FDA Link 12/2001
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2001
1	Plant Oils (Vegetable Oils)IBA 11/2001
1	C-PeptideIBA 11/2001
1	CytokinesIBA 11/2001
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2001
1	Mannitol (Osmitrol)FDA LinkGeneric 11/2001
1	CreatinineIBA 09/2001
1	Amlodipine (Norvasc)FDA LinkGeneric 09/2001
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2001
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2000
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2000
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2000
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2000

Therapy/Procedure

3	Therapeutics 05/2014 - 11/2004
2	Surgical Amputation (Amputations) 07/2013 - 11/2004
1	Debridement 11/2004
1	Artificial Skin 11/2004
1	Surgical Instruments (Clip) 12/2001
1	Nephrectomy 12/2001
1	Subcutaneous Injections 11/2001
1	Injections 11/2001
1	Immunomodulation 11/2001